TARGETING TUMOR MICROENVIRONMENT-ASSOCIATED IMMUNE CELLS WITH NANOPARTICLES-BASED STRATEGIES

被引:2
|
作者
Alotaibi, Najla Suhail [1 ]
机构
[1] King Abdulaziz Univ, King Fahad Med Res Ctr, Immunol Unit, Jeddah, Saudi Arabia
来源
PHARMACOPHORE | 2021年 / 12卷 / 04期
关键词
Tumor microenvironment; Nanoparticles; Nanotechnology; Cancer; Immunotherapy; SUPPRESSOR-CELLS; DENDRITIC CELLS; MACROPHAGE POLARIZATION; CANCER; ACTIVATION; OLIGODEOXYNUCLEOTIDES; PROGRESSION; METASTASIS; INHIBITION; EXPRESSION;
D O I
10.51847/PJ1xCWaW3U
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The propensity of cancer cells to escape the immune system and to initiate a complex balance environment is due to its ability to utilize immune cells via associated factors, including non-tumoral components such as blood vessels, fibroblasts, cells, and signaling molecules. Collectively, these are referred to as the tumor microenvironment (TME). TME is the tumor's surrounding environment and has a crucial role in promoting tumor progression, angiogenesis, metastasis, and increasing tumor resistance to several therapies. TME's immunosuppressive factors depress the immune response after altering the metabolism of immune cells within TME. Accordingly, targeting TME with nanoparticles may be a beneficial tool to regulate and enhance the efficacy of tumor immunotherapies. Here, we review distinct structural and functional properties of immune cells within TME, tumor-associated immunosuppressive factors, and the interaction between TME and immune cells. We finish with a summary of recent findings related to novel nanoparticle strategies to target TME. Copyright (C) 2013 - All Rights Reserved -Pharmacophore
引用
收藏
页码:1 / 10
页数:10
相关论文
共 50 条
  • [21] The Role of the Tumor vasculature in the Host immune Response: implications for Therapeutic Strategies Targeting the Tumor Microenvironment
    Hendry, Shona A.
    Farnsworth, Rae H.
    Solomon, Benjamin
    Achen, Marc G.
    Stacker, Steven A.
    Fox, Stephen B.
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [22] Tumor microenvironment highlighting tumor-associated macrophages and immune cells
    Zangrandi, Giulio Lodetti
    Tirpanlar, Dilruba
    Pastore, Mirella
    Soldani, Cristiana
    Lleo, Ana
    Raggi, Chiara
    HEPATOMA RESEARCH, 2023, 9
  • [23] Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges
    Hao, Xiaopei
    Sun, Guangshun
    Zhang, Yao
    Kong, Xiangyi
    Rong, Dawei
    Song, Jinhua
    Tang, Weiwei
    Wang, Xuehao
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [24] Peptide-assembled nanoparticles targeting tumor cells and tumor microenvironment for cancer therapy
    Zhang, Meichen
    Xu, Haiyan
    FRONTIERS IN CHEMISTRY, 2023, 11
  • [25] Tumor targeting strategies for chitosan-based nanoparticles
    Zhang, Xingzhen
    Yang, Xiaoye
    Ji, Jianbo
    Liu, Anchang
    Zhai, Guangxi
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2016, 148 : 460 - 473
  • [26] Gemini nanoparticles-based quadruple therapy (GNQT) achieved effective tumor immunotherapy by comprehensive regulation of tumor microenvironment
    Guo, Xiaoya
    Wu, Jiayan
    Feng, Yuanji
    Yang, Zhiyu
    Fang, Huapan
    Chen, Jie
    Guo, Zhaopei
    Lin, Lin
    Pang, Xuan
    Tian, Huayu
    NANO TODAY, 2023, 51
  • [27] Immune Cells in Tumor Microenvironment
    Song Nan
    Li Tao
    Zhang Xue-Min
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2014, 41 (10) : 1075 - 1084
  • [28] TUMOR MICROENVIRONMENT-ASSOCIATED PROGNOSTICATORS DIFFER BETWEEN PEDIATRIC AND ADULT HODGKIN LYMPHOMA
    Gupta, Sumit
    Yeh, Stacy
    Chami, Rose
    Punnett, Angela
    Chung, Catherine
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S42 - S43
  • [29] Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function
    Rossi, Gustavo Rodrigues
    Trindade, Edvaldo S.
    Souza-Fonseca-Guimaraes, Fernando
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [30] Targeting macrophages to reprogram the tumor immune microenvironment
    Xie, Zhidong
    Liao, Jing
    Chen, Jun
    BLOOD SCIENCE, 2024, 6 (04):